M&A seminar: EU legal & regulatory aspects

Some time ago I wrote about issues often overlooked in medical devices M&A transactions. Because of the reactions to it I decided to organise a seminar at my law firm’s Amsterdam office about it on Wednesday 13 April that should provide a good insights in the subject. With speakers from notified body BSi (Jan van Lochum, vice president Healthcare), from DRS regulatory consultants (Hans van Dulmen) and of course myself you will get a good insight in the regulatory and legal aspects of mergers and acquisitions in the medical devices company. The seminar is free and will be made available in real time as webinar, so if you cannot travel you can participate if you have a computer with internet connection and a telephone. Participation is free. I hope to welcome many of my readers!

Here is the invitation, just for good measure (you may need to click the CT screen to start the animation and see the invite):

Information and Registration

Wednesday, April 13, 2011

Greenberg Traurig, LLP
Atrium Building, 8th floor
Strawinskylaan 3127
1077 ZX Amsterdam

Registration and coffee: 15.30
Seminar starts: 16.00
Drinks and snacks: 18.30

This seminar will provide a unique opportunity to hear about mergers and acquisitions (M&A) in the medical device industry from a notified body, from a regulatory consultant and from the legal viewpoint, ensuring high quality yet practical content and ample opportunity to get your questions answered.

To register for this seminar, please send an email to medtech@eu.gtlaw.com with your name, the names of any colleagues you would like to register, and your contact information.

To register for the webinar, please click here.

Whether you will attend in person or online, your response is requested no later than Wednesday, April 6.

If you have any questions about this seminar, please contact Wycke van der Ploeg  at vanderploegw@eu.gtlaw.com or +31 (0) 20 30 17 400.


Navigate through our knowledgebase

Related articles

Article

Commission working on proposal to postpone MDR date of application for one year

After a statement on a press conference today by Stefan De keersmaecker that had many people very excited quickly, the official announcement came later in the afternoon: Here is what I think about…

Read more

Article

The MDCG guidance on significant changes – a significant change?

It’s hard to keep up with all the work and the new publications of guidance these days. Abundance creates its own problems one could say, so that’s why this blog was slightly…

Read more

Article

The MDCG guidance on significant changes – a significant change?

It’s hard to keep up with all the work and the new publications of guidance these days. Abundance creates its own problems one could say, so that’s why this blog was slightly delayed. Due to the COVID-19 epidemic I have had to home quarantine the family, move the whole law firm to a virtual platform […]